- Conditions
- Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,021 public trials
2,029 recruiting studies
Lymphoproliferative Disorders trial results
NCT07098364
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +20 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT07082803
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Stanford Medicine Cancer Center Palo Alto, California, United States
- The START Center for Cancer Care - Midwest Grand Rapids, Michigan, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Recruiting
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
NCT06651177
- Conditions
- Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Gateway Community Services Jacksonville, Florida, United States
- IBIS Behavioral Health Tampa, Florida, United States
- Ruth M. Rothstein CORE Center Chicago, Illinois, United States
- The Gibson Center for Behavioral Change Cape Girardeau, Missouri, United States
- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT04879043
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Norton Healthcare, Inc. Louisville, Kentucky, United States
- Nebraska Cancer Institute Omaha, Nebraska, United States
- Mount Sinai, The Tisch Cancer Instutute New York, United States
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012
NCT06565689
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
NCT05237986
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- Children s Hospital of Los Angeles Los Angeles, California, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Seattle Children s Hospital Seattle, Washington, United States
NCT05289687
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Northwestern Chicago, Illinois, United States
NCT03986034
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States